Clinical Trials

140 enrolled

Carcinoma, Hepatocellular

NCT07162506 2026-05-19

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

120 enrolled

Esophageal Neoplasms

NCT06758830 2026-05-11

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Phase 2/3 Recruiting

400 enrolled

Low Anterior Resection Syndrome, Fatigue, Postoperative Complications, Radiation Injuries, Rectal Neoplasms

NCT07000253 2026-05-07

OMEC-5

Phase 2/3 Recruiting

290 enrolled

Esophageal Neoplasms, Neoplasms, Stomach Neoplasms

NCT06307548 2026-05-06

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Phase 1/2 Recruiting

21 enrolled

Colorectal Neoplasms

NCT06576921 2026-04-23

Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction

116 enrolled

Stomach Neoplasms

NCT06850103 2026-03-25

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

51 enrolled

Colorectal Neoplasms

NCT06269978 2026-03-10

Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer

Phase 1 Recruiting

24 enrolled

Colorectal Neoplasms

NCT04215731 2026-03-03

FOBEAR

582 enrolled

Rectal Neoplasms

NCT04821843 2026-01-21

Neoadjuvant Treatment Modalities in Esophageal Cancer

2,000 enrolled

Esophageal Neoplasms

NCT06468280 2026-01-21

ROSETTE

84 enrolled

Stomach Neoplasms

NCT04587739 2025-12-23

KARCHER-1

Phase 1 Recruiting

30 enrolled

Carcinoma, Hepatocellular

NCT06940947 2025-11-20

ETHOS

434 enrolled

Colonic Neoplasms

NCT04809025 2025-09-29

EBPS

510 enrolled

Stomach Neoplasms

NCT07194616 2025-09-26

Rectal Cancer CTC Trial

120 enrolled

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT07183280 2025-09-19

SPN

2,000 enrolled

Solid Pseudopapillary Neoplasm of the Pancreas

NCT06574373 2025-09-03

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

3,600 enrolled

Pancreatic Intraductal Neoplasms, Pancreatic Neoplasms

NCT05265208 2025-08-06

SIROCHO

62 enrolled

Resectable Intrahepatic Cholangiocarcinoma

NCT06476067 2025-07-11

Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma

150 enrolled

Esophageal Neoplasms, Recurrence

NCT04958720 2025-07-03

AGAMENON

10,000 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT06906887 2025-06-29

PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer

50 enrolled

Esophageal Neoplasms, Esophagitis

NCT06908031 2025-05-14

CRIT

49 enrolled

Rectal Neoplasms

NCT06898398 2025-04-03

TACE Combined Surgery for the Resectable Huge HCC

326 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06293625 2025-03-30

FOxTROT2France

150 enrolled

Colonic Neoplasms

NCT02972372 2025-02-10

CELAEC

196 enrolled

Esophageal Neoplasms

NCT04890171 2024-12-27

ERASE-GC

708 enrolled

Stomach Neoplasms

NCT06721286 2024-12-06

Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma

70 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT06628661 2024-11-20

Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 cm and Microvascular Invasion

3,000 enrolled

Carcinoma, Hepatocellular

NCT05964530 2024-09-20

Radical vs Local Excision for Rectal Cancer With Clinically Complete Remission

180 enrolled

Rectal Neoplasms

NCT06387810 2024-07-10

undetermined

45 enrolled

Phase EARLY_PHASE1 Recruiting

Borderline Resectable Pancreatic Cancer

NCT06326736 2024-03-22

Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer

12 enrolled

Pancreatic Neoplasms

NCT04597294 2024-03-06

CHIMERA

600 enrolled

Stomach Neoplasms

NCT03125343 2023-11-07

WoW

400 enrolled

Pathologic Complete Response, Rectal Neoplasms

NCT03964753 2023-10-10

NTNC

202 enrolled

Esophageal Squamous Cell Carcinoma

NCT05939661 2023-07-11

AMBITION

45 enrolled

Rectal Neoplasms

NCT05083247 2023-05-23

STEREOPAC

256 enrolled

Pancreatic Neoplasms

NCT05201430 2022-03-04

RCNAC

300 enrolled

Rectal Neoplasms

NCT04777942 2021-03-02

Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)

320 enrolled

Carcinoma, Hepatocellular

NCT04288999 2020-06-04

JCOG1801

110 enrolled